Abstract
Currently, many immuno-inflammatory processes have been associated with coronary disease atherosclerosis, pointing to harmful effects on the activation of macrophages and a beneficial involvement of antibodies and their fragments directed against the low-density-lipoprotein (LDL) oxidized. With this comes the need for research methods obteção these products, in which biotechnology has bee…